Skip navigation

Improve Outcomes through Innovative Analysis and Application of Patient Data

January 27-28, 2020
  • Miami, FL

CBI’s Patient Registries, Real World Evidence and HEOR discusses the latest innovations and best practices for collecting, analyzing and utilizing patient data. From a variety of critical perspectives, you’ll hear about the latest successes and challenges for building and sustaining patient registries and applying Real World and HEOR data. With three dedicated tracks — Patient Registries, RWE, HEOR — the conference focuses on common goals for participants centered on using data to improve treatments and outcomes.

NEW for 2020! 3 In-Depth Tracks Focusing on:
Patient Registries, Real World Evidence and
Health Economics & Outcomes Research

Featuring Discussions of
Critical Content Including:

  • The Future of Registries and Real World Evidence —
    Realizing Mutual Goals for Patients, Payers, Providers & Pharma
  • Emerging Opportunities to Use RWE for Regulatory Submission
  • Novel Methods of Database Analysis
  • Global Use of Registries and RWE — US, EU, Canada, Asia
  • Engaging Patients and Improving Access to RWE and
    Patient Registries
  • Approaches to Analyzing HEOR Data & Economic Modeling
  • And more!
WHAT THE INDUSTRY IS SAYING
Quotes from the Indutry

Patient Registries, Real World Evidence and HEOR

Improve Outcomes through Innovative Analysis and Application of Patient Data

CBI’s Patient Registries, Real World Evidence and HEOR discusses the latest innovations and best practices for collecting, analyzing and utilizing patient data. From a variety of critical perspectives, you’ll hear about the latest successes and challenges for building and sustaining patient registries and applying Real World and HEOR data. With three dedicated tracks — Patient Registries, RWE, HEOR — the conference focuses on common goals for participants centered on using data to improve treatments and outcomes.

NEW for 2020! 3 In-Depth Tracks Focusing on:
Patient Registries, Real World Evidence and
Health Economics & Outcomes Research

Featuring Discussions of
Critical Content Including:

  • The Future of Registries and Real World Evidence —
    Realizing Mutual Goals for Patients, Payers, Providers & Pharma
  • Emerging Opportunities to Use RWE for Regulatory Submission
  • Novel Methods of Database Analysis
  • Global Use of Registries and RWE — US, EU, Canada, Asia
  • Engaging Patients and Improving Access to RWE and
    Patient Registries
  • Approaches to Analyzing HEOR Data & Economic Modeling
  • And more!
WHAT THE INDUSTRY IS SAYING
Quotes from the Indutry